Table 1.
Summary of baseline continuous covariates by disease
| Covariate, median (range) | ALL overall (n = 234) |
NHL overall (n = 531) |
Total (N = 765) |
|---|---|---|---|
| Age, years |
46.0 (20.0–79.0) |
65.0 (18.0–92.0) |
61.0 (18.0–92.0) |
| Body weight, kg |
74.0 (30.9–154) |
73.2 (33.5–148) |
73.3 (30.9–154) |
| Body surface area, m2 |
1.86 (1.27–2.81) |
1.83 (1.13–2.56) |
1.84 (1.13–2.81) |
| Creatinine clearance, mL/min |
122 (29.4–368) |
81.8 (18.2–264) |
93.1 (18.2–368) |
| Albumin, g/dL |
3.80 (1.80–4.93) |
4.00 (2.20–5.20) |
3.92 (1.80–5.20) |
| Aspartate aminotransferase, U/L |
26.0 (5.00–187) |
24.5 (7.00–163) |
25.0 (5.00-187) |
| Alanine aminotransferase, U/L |
33.0 (5.00–161) |
20.4 (3.00–236) |
22.0 (3.00–236) |
| Total bilirubin, mg/dL |
0.500 (0.100–2.16) |
0.499 (0.100–3.90) |
0.499 (0.100–3.90) |
| Absolute blast counts in peripheral blood, × 109 |
0.823 (0.00–254) |
NA |
0.823 (0.00–254) |
| Absolute CD22+ blast counts in peripheral blood, × 109 |
0.442 (0.00–252) |
NA |
0.442 (0.00–252) |
| Blasts in peripheral blood, % |
4.00 (0.00–100) |
NA |
4.00 (0.00–100) |
| Blasts that are CD22+ in peripheral blood, % |
98.7 (11.4–100) |
NA |
98.7 (11.4–100) |
Summary statistics were calculated prior to any covariate imputations
NA not applicable